Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE

(ABBV)
  Report  
Delayed Quote. Delayed Nyse - 12/13 04:02:18 pm
87.84 USD   -1.00%
12/13ABBVIE : Form 8.3 -
DJ
12/12ABBVIE : Form 8.3 -AbbVie Inc
DJ
12/12ABBVIE : Form 8.3 -AbbVie Inc
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société ABBVIE
12/12ABBVIE : Form 8.3 -AbbVie Inc
AQ
12/11ABBVIE : Form 8.3 -
AQ
12/09ABBVIE : More than Seven-Year Analysis of Early Treatment with IMBRUVICA Monothe..
AQ
12/09ABBVIE : New Long-Term Data Continues to Demonstrate Progression-Free Survival a..
AQ
12/09ABBVIE : IMBRUVICA plus VENCLEXTA/VENCLYXTO Combination Data Show High Rates of ..
AQ
12/09ALECTOR : Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheim..
AQ
12/09ABBVIE : and Scripps Research announce collaboration to develop a broad range of..
PR
12/06ABBVIE : reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCP..
AQ
12/02ABBVIE : Form 8.3 -
AQ
11/29ABBVIE : Form 8.3 -
AQ
11/26ABBVIE INC. : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
11/22HARPOON THERAPEUTICS : and AbbVie Announce Licensing and Option Collaboration to..
AQ
11/22ABBVIE : to Present Latest Clinical Research in the Treatment of Leukemias, Lymp..
AQ
11/20ABBVIE : Form 8.3 -
AQ
11/20ABBVIE : Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmu..
PR
11/18ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/18ABBVIE : Announces Extension of Expiration Date for Exchange Offers for Allergan..
PR
11/13ABBVIE INC. : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
11/12ABBVIE : Prices $30 Billion of Senior Unsecured Notes
PR
11/11ABBVIE : Form 8.3 -
AQ
11/11ABBVIE : Submits Supplemental New Drug Application to U.S. FDA for IMBRUVICA in ..
AQ
11/07ABBVIE : Announces Results of Early Participation in Exchange Offers and Consent..
PR
11/07ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/06ABBVIE INC. : Regulation FD Disclosure, Other Events, Financial Statements and E..
AQ
11/06ABBVIE : Announces Launch of Private Offering of Senior Unsecured Notes
PR
11/06ABBVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
11/06ABBVIE : Form 8.3 -
AQ
11/05ABBVIE : Form 8.3 -
AQ
11/05ABBVIE : to Showcase Depth of Immunology Portfolio and Pipeline at the 2019 ACR/..
AQ
11/04ABBVIE : Reports Third-Quarter 2019 Financial Results
AQ
11/01ABBVIE : 3Q Earnings Snapshot
AQ
11/01ABBVIE INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
11/01ABBVIE : Reports Third-Quarter 2019 Financial Results
PR
11/01ABBVIE : RINVOQ Meets Primary and All Ranked Secondary Endpoints in Phase 3 Stud..
AQ
10/31ABBVIE : Form 8.3 -
AQ
10/29ABBVIE : Launches Let Me Be Clear to Empower People with Psoriasis to Speak Up a..
PR
10/28ABBVIE : Announces Commencement of Exchange Offers and Consent Solicitations for..
AQ
10/25ABBVIE : Form 8.3 - AbbVie Inc
AQ
10/25ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/24ABBVIE : to Present at the Wolfe Research Inaugural Healthcare Conference
PR
10/24ABBVIE : Announces Collaboration with Cystic Fibrosis Foundation
PR
10/23ABBVIE : Suzanne Campbell recognized by peers
AQ
10/22ABBVIE INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, F..
AQ
10/21ABBVIE : Form 8.3 - AbbVie Inc
AQ
10/21ABBVIE : Receives CHMP Positive Opinion for Upadacitinib for the Treatment of Ad..
AQ
10/18ABBVIE : 25-nse
PU
10/18ABBVIE : Receives CHMP Positive Opinion for Upadacitinib (RINVOQ™) for the..
PR
10/09ABBVIE : Announces New Data from its Dermatology Portfolio and Pipeline at the 2..
AQ
10/09ABBVIE : Announces New Data from its Dermatology Portfolio and Pipeline at the 2..
PR
10/08ABBVIE : to Host Third-Quarter 2019 Earnings Conference Call
PR
10/01ABBVIE : Statement of changes in beneficial ownership of securities
PU
09/30ALLERGAN : and AbbVie Receive Second Request from Federal Trade Commission on Pe..
AQ
09/30ABBVIE : and Allergan Receive Second Request from Federal Trade Commission on Pe..
AQ
09/27ABBVIE : Receives FDA Approval of MAVYRET to Shorten Treatment Duration to Eight..
AQ
09/26ABBVIE : Registration of certain classes of securities 12(b) of the Securities E..
PU
09/26ABBVIE INC. : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
09/26ABBVIE : Form 8.3 - AbbVie Inc
AQ
09/25ABBVIE : VENCLEXTA®, a treatment for chronic lymphocytic leukemia (CLL), now rei..
AQ
09/23ABBVIE INC. : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
09/23ABBVIE INC. : - Despatch of Option Holder Proposal Letters
AQ
09/23ABBVIE : to Present New and Updated Data From 22 Abstracts, Including Two Late-B..
PR
09/19ABBVIE : Form of prospectus disclosing information, facts, events covered in bot..
PU
09/16ABBVIE : Form 8.3 - AbbVie Inc
AQ
09/16ABBVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
09/16ABBVIE : Form of prospectus reflecting facts events constituting substantive cha..
PU
09/16ABBVIE : Report of unscheduled material events or corporate event
PU
09/16ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/12ABBVIE : Form 8.3 -
AQ
09/11UPDATE : Form 8.3 - AbbVie Inc (Correction of Doc)
AQ
09/09ABBVIE : Declares Quarterly Dividend
AQ
09/06ABBVIE : Declares Quarterly Dividend
PR
09/04ABBVIE : Form 8.3 - AbbVie Inc
AQ
08/30ABBVIE : Report of unscheduled material events or corporate event
PU
08/30ABBVIE INC. : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
08/30ABBVIE : Discontinues Rovalpituzumab Tesirine Research and Development Program
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ABBVIE